LPR Fluorescence Pilot

N/AUnknownNCT05204303

The Functional Gut Clinic100 enrolled

Overview

Comparing the fluorescence signatures from mouthwash samples of patients with laryngopharyngeal reflux (LPR) and healthy volunteers.

The investigators aim to test if the biosensing platform Pandra, developed by Rosa Biotech, may be suitable to distinguish patients with LPR symptoms, both with and without objective evidence of gastroesophageal reflux disease (GORD), vs healthy volunteers due to their expected inflammation and cell changes in the laryngo-pharyngeal region. The investigators intend to analyse 20 samples of mouthwash solutions from each of the following groups: A. Patients with symptoms of LPR and objective evidence of GORD B. Patients with symptoms of LPR and no objective evidence of GORD C. Healthy volunteer group

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Laryngopharyngeal Reflux Gastro Esophageal Reflux

Interventions

24-hour pH-impedance monitoringDIAGNOSTIC_TEST

Ambulatory transnasal reflux device to detect reflux events in the oeosphagus and pharynx.

Symptom questionnairesOTHER

Reflux Symptom Index (RSI) Gastroesophageal Reflux Disease Questionnaire (GERDQ) Short-form Esophageal Hypervigilance and Anxiety Scale (SF-EHAS)

ROME IV Diagnostic QuestionnaireOTHER

A symptom-based questionnaire used to diagnose disorders of gut-brain interaction (DGBI)

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Healthy Volunteers Inclusion Criteria: * Participant is Aged 18 or above * Participant has capacity to understand written English * Participant is not on regular prescription medicines * Participant has an RSI score of 0 * Participant has a body mass index (BMI) of 18.5 - 34.9 kg/m2 (bounds included) Exclusion Criteria: * Participant has experienced any symptoms of LPR or GORD symptoms in the past year * Participant has taken any medication for GORD/LPR in the past year (e.g. proton pump inhibitors, h2 antagonists, over the counter antacids) * Participant has active oral disease * Participant has a significant medical diagnosis Patients with symptoms of LPR Inclusion Criteria: * Participant is Aged 18 or above * Participant has capacity to understand written English * Participant has an RSI score of \>13 * Participant has a body mass index (BMI) of 18.5 - 34.9 kg/m2 (bounds included * Participant has been referred for 24hr ambulatory pH-impedance monitoring Exclusion Criteria: * Participant has active oral disease * Participant has other ongoing health problems that could account for their LPR symptoms. * Participant has NOT undergone nasoendoscopy within last 6 months OR does not have one scheduled within next 6 weeks * Previous antireflux surgery (e.g. fundoplication or magnetic sphincter augmentation) * Previous bariatric surgery (e.g. gastric bypass or sleeve gastrectomy)

Locations (1)

The Functional Gut Clinic

Manchester, Greater Manchester, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

Determine the detection strength of differences in fingerprints between the three participant groups.

Time frame: 10-months

Secondary Outcomes

Determine the differences in fingerprints between samples within one group to assess background noise.

Time frame: 10-months

Determine the feasibility of mouthwash on Pandra platform.

Time frame: 10-months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.